MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion

Journal of Pathology

Volumn 231, Issue 3, 2013, Pages 388-399

  Verghese, Eldo T ^a   Drury, Ruth ^a   Green, Caroline A ^a   Holliday, Deborah L ^a   Lu, Xiaomei ^a   Nash, Claire ^a   Speirs, Valerie ^a   Thorne, James L ^a   Thygesen, Helene H ^a   Zougman, Alexandre ^a   Hull, Mark A ^a   Hanby, Andrew M ^a   Hughes, Thomas A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

fibroblast; microRNA; microRNA 26b; stroma; tumour microenvironment

Indexed keywords

CELL PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFIC FACTOR 7; COLLAGEN TYPE XII ALPHA 1; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 107; MICRORNA 15B; MICRORNA 26B; MICRORNA 7F; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TANKYRASE 1 BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RECURRENCE; CARCINOMA ASSOCIATED FIBROBLAST; CELL MIGRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FIBROBLAST; GLYCOLYSIS; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR INVASION;

FIBROBLAST; MICRORNA; MICRORNA-26B; STROMA; TUMOUR MICROENVIRONMENT;

BREAST NEOPLASMS; CELL MOVEMENT; COCULTURE TECHNIQUES; DOWN-REGULATION; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARACRINE COMMUNICATION; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 84885406105     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4248     Document Type: Article

References (52)

1. Ronnov-Jessen L, Petersen OW, Bissell MJ,. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76: 69-125.
2. Bhowmick NA, Neilson EG, Moses HL,. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
3. Kojima Y, Acar A, Eaton EN, et al., Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A 2010; 107: 20009-20014.
4. Polyak K, Kalluri R,. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harbor Perspect Biol 2010; 2: a003244.
5. Finak G, Bertos N, Pepin F, et al., Stromal gene expression predicts clinical outcome in breast cancer. Nature Med 2008; 14: 518-527.
6. Orimo A, Gupta PB, Sgroi DC, et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
7. Sugimoto H, Mundel TM, Kieran MW, et al., Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5: 1640-1646.
8. Kuperwasser C, Chavarria T, Wu M, et al., Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 2004; 101: 4966-4971.
9. Trimboli AJ, Cantemir-Stone CZ, Li F, et al., Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084-1091.
10. Hu M, Yao J, Cai L, et al., Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet 2005; 37: 899-905.
11. Siletz A, Kniazeva E, Jeruss JS, et al., Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts. Cancer Microenviron 2013; 6: 91-107.
12. Patocs A, Zhang L, Xu Y, et al., Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007; 357: 2543-2551.
13. Friedman RC, Farh KK, Burge CB, et al., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
14. Guo H, Ingolia NT, Weissman JS, et al., Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840.
15. Verghese ET, Hanby AM, Speirs V, et al., Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol 2008; 215: 214-221.
16. Ma L, Teruya-Feldstein J, Weinberg RA,. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688.
17. Huang Q, Gumireddy K, Schrier M, et al., The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biol 2008; 10: 202-210.
18. Si ML, Zhu S, Wu H, et al., miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
19. Rask L, Balslev E, Jorgensen S, et al., High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 2011; 119: 663-673.
20. Zhao L, Sun Y, Hou Y, et al., MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. Int J Biochem Cell Biol 2012; 44: 2051-2059.
21. Sung CO, Lee KW, Han S, et al., Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes. Am J Pathol 2011; 179: 1827-1838.
22. Qiu W, Hu M, Sridhar A, et al., No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nature Genet 2008; 40: 650-655.
23. Hughes TA, Brady HJ,. Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death. Exp Cell Res 2005; 303: 32-46.
24. Simpkins SA, Hanby AM, Holliday DL, et al., Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol 2012; 227: 490-498.
25. Verghese ET, Shenoy H, Cookson VJ, et al., Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized beta-catenin in carcinoma-associated fibroblasts. Histopathology 2011; 59: 609-618.
26. Madhok BM, Yeluri S, Perry SL, et al., Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells. Br J Cancer 2010; 102: 1746-1752.
27. Nowicki MO, Dmitrieva N, Stein AM, et al., Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro-oncology 2008; 10: 690-699.
28. Yu M, Ting DT, Stott SL, et al., RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012; 487: 510-513.
29. Wisniewski JR, Zougman A, Nagaraj N, et al., Universal sample preparation method for proteome analysis. Nature Methods 2009; 6: 359-362.
30. Cox J, Matic I, Hilger M, et al., A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nature Protoc 2009; 4: 698-705.
31. Smyth GK,. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
32. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc 1995; 57: 289-300.
33. Ma YL, Zhang P, Wang F, et al., Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. J Cell Mol Med 2011; 15: 1941-1954.
34. Hooper S, Marshall JF, Sahai E,. Tumor cell migration in three dimensions. Methods Enzymol 2006; 406: 625-643.
35. Xouri G, Christian S,. Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 2010; 21: 40-46.
36. Wu N, Zhao X, Liu M, et al., Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One 2011; 6: e16264.
37. Liu X, Chen Z, Yu J, et al., MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009; 837514.
38. Ji J, Shi J, Budhu A, et al., MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-1447.
39. Liu XX, Li XJ, Zhang B, et al., MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011; 585: 1363-1367.
40. Seimiya H, Smith S,. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J Biol Chem 2002; 277: 14116-14126.
41. Kim S, Yamamoto J, Chen Y, et al., Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation. Genes Cells 2010; 15: 1003-1013.
42. Karagiannis GS, Petraki C, Prassas I, et al., Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 2012; 3: 267-285.
43. Baek D, Villen J, Shin C, et al., The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
44. Niu HT, Yang CM, Jiang G, et al., Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery. J Cancer Res Clin Oncol 2011; 137: 1273-1282.
45. Pavlides S, Whitaker-Menezes D, Castello-Cros R, et al., The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8: 3984-4001.
46. Migneco G, Whitaker-Menezes D, Chiavarina B, et al., Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010; 9: 2412-2422.
47. Spiering D, Hodgson L,. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr 2011; 5: 170-180.
48. Goetz JG, Minguet S, Navarro-Lerida I, et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011; 146: 148-163.
49. Gaggioli C, Hooper S, Hidalgo-Carcedo C, et al., Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature Cell Biol 2007; 9: 1392-1400.
50. Keene DR, Lunstrum GP, Morris NP, et al., Two type XII-like collagens localize to the surface of banded collagen fibrils. J Cell Biol 1991; 113: 971-978.
51. Hattermann K, Held-Feindt J, Mentlein R,. Spheroid confrontation assay: a simple method to monitor the three-dimensional migration of different cell types in vitro. Ann Anat 2011; 193: 181-184.
52. Lyng MB, Laenkholm AV, Sokilde R, et al., Global microRNA expression profiling of high-risk ER + breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PloS One 2012; 7: e36170.